Monthly Archives: June 2012

Lorcaserin approved by FDA

Posted on June 28, 2012 by pharminpt

Yesterday, the U.S. Food and Drug Administration approved the weight loss drug lorcaserin (Belviq®, Arena Pharmaceuticals). This is the first approval for an obesity treatment since orlistat (Xenical®) in 1999. The effect on weight loss is modest (3-5%) and the … Continue reading →

Posted in plasma glucose, weight loss | Tagged , , , | Leave a comment

Oh, the Medicines You’ll Take!

Posted on June 28, 2012 by pharminpt

An Update on Pediatric Drug Utilization Drugs aren’t just for grown ups, but it would appear that kids are being prescribed fewer medications than they used to be back in the day, all the way back in 2002.1 The data, published … Continue reading →

Posted in general | Tagged , , , , , | Leave a comment

Adverse drug events in the ICU – do they happen and do they matter?

Posted on June 22, 2012 by pharminpt

Physical Therapists in Intensive Care With all the talk lately about early mobilization in the ICU (a recent systematic review, Amy Pawlik’s standing room only presentation at CSM 2012), it’s evident that physical therapists and other rehabilitation professionals are only … Continue reading →

Posted in general | Tagged , , , | Leave a comment